- Home
- SCOR vs BRNS Comparison
SCOR vs BRNS Comparison
Compare SCOR & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- BRNS
- Stock Information
- Founded
- SCOR 1999
- BRNS 2016
- Country
- SCOR United States
- BRNS United Kingdom
- Employees
- SCOR N/A
- BRNS N/A
- Industry
- SCOR Business Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- BRNS Health Care
- Exchange
- SCOR Nasdaq
- BRNS Nasdaq
- Market Cap
- SCOR 27.7M
- BRNS 28.2M
- IPO Year
- SCOR 2007
- BRNS 2021
- Fundamental
- Price
- SCOR $5.50
- BRNS $0.84
- Analyst Decision
- SCOR Buy
- BRNS Strong Buy
- Analyst Count
- SCOR 2
- BRNS 2
- Target Price
- SCOR $10.75
- BRNS $3.00
- AVG Volume (30 Days)
- SCOR 8.8K
- BRNS 25.3K
- Earning Date
- SCOR 05-06-2025
- BRNS 05-12-2025
- Dividend Yield
- SCOR N/A
- BRNS N/A
- EPS Growth
- SCOR N/A
- BRNS N/A
- EPS
- SCOR N/A
- BRNS N/A
- Revenue
- SCOR $356,047,000.00
- BRNS $14,969,000.00
- Revenue This Year
- SCOR $4.38
- BRNS N/A
- Revenue Next Year
- SCOR $3.97
- BRNS N/A
- P/E Ratio
- SCOR N/A
- BRNS N/A
- Revenue Growth
- SCOR N/A
- BRNS 1766.46
- 52 Week Low
- SCOR $4.59
- BRNS $0.64
- 52 Week High
- SCOR $15.69
- BRNS $2.60
- Technical
- Relative Strength Index (RSI)
- SCOR 46.17
- BRNS 51.29
- Support Level
- SCOR $4.59
- BRNS $0.68
- Resistance Level
- SCOR $5.63
- BRNS $0.97
- Average True Range (ATR)
- SCOR 0.61
- BRNS 0.08
- MACD
- SCOR -0.01
- BRNS 0.02
- Stochastic Oscillator
- SCOR 53.22
- BRNS 55.69
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.